NDC 67296-1818

Tivicay

Dolutegravir Sodium

Tivicay is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Redpharm Drug, Inc.. The primary component is Dolutegravir Sodium.

Product ID67296-1818_b0016570-7e04-02f6-e053-2995a90a95b4
NDC67296-1818
Product TypeHuman Prescription Drug
Proprietary NameTivicay
Generic NameDolutegravir Sodium
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2013-08-13
Marketing CategoryNDA / NDA
Application NumberNDA204790
Labeler NameRedPharm Drug, Inc.
Substance NameDOLUTEGRAVIR SODIUM
Active Ingredient Strength50 mg/1
Pharm ClassesHIV Integrase Inhibitors [MoA],Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC],Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA],Organic Cation Transporter 2 Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 67296-1818-3

3 TABLET, FILM COATED in 1 BOTTLE (67296-1818-3)
Marketing Start Date2013-08-13
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Tivicay" or generic name "Dolutegravir Sodium"

NDCBrand NameGeneric Name
49702-226Tivicaydolutegravir sodium
49702-227Tivicaydolutegravir sodium
49702-228Tivicaydolutegravir sodium
50090-1355Tivicaydolutegravir sodium
53808-1130Tivicaydolutegravir sodium
67296-1818Tivicaydolutegravir sodium
70518-1487Tivicaydolutegravir sodium
49702-255Tivicay PDdolutegravir sodium

Trademark Results [Tivicay]

Mark Image

Registration | Serial
Company
Trademark
Application Date
TIVICAY
TIVICAY
77509933 not registered Dead/Abandoned
GLAXOSMITHKLINE LLC
2008-06-27
TIVICAY
TIVICAY
77063119 3618019 Live/Registered
VIIV HEALTHCARE COMPANY
2006-12-13

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.